Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$274M |
| 2 |
FRLG
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
|
+$138M |
| 3 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$69.1M |
| 4 |
Lumentum
LITE
|
+$41.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$171M |
| 2 |
Petrobras
PBR
|
+$64.7M |
| 3 |
Vale
VALE
|
+$62.7M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$61.9M |
| 5 |
HDFC Bank
HDB
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 10.74% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Energy | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Evercore
EVR
$12.4B
| $947K | ﹤0.01% |
12,668
-117,749
| -90% | -$8.97M |
|
527
iShares Russell 2000 ETF
IWM
$79.8B
| $937K | ﹤0.01% |
5,655
+3,073
| +119% | +$486K |
|
|
LPT
528
DELISTED
Liberty Property Trust
LPT
| $935K | ﹤0.01% |
15,572
-51,508
| -77% | -$2.95M |
|
|
DNKN
529
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $931K | ﹤0.01% |
12,318
+1,941
| +19% | +$147K |
|
530
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $929K | ﹤0.01% |
17,274
+5,963
| +53% | +$307K |
|
|
K
531
DELISTED
Kellanova
K
| $927K | ﹤0.01% |
14,275
-198
| -1% | -$12K |
|
532
Ring Energy
REI
$315M
| $927K | ﹤0.01% |
351,277
| – | – |
|
533
Energizer
ENR
$1.44B
| $916K | ﹤0.01% |
18,230
-64,471
| -78% | -$2.97M |
|
534
iShares MSCI Switzerland ETF
EWL
$2.19B
| $892K | ﹤0.01% |
21,956
+1,217
| +6% | +$47K |
|
535
Globant
GLOB
$1.58B
| $889K | ﹤0.01% |
8,384
+205
| +3% | +$20.4K |
|
536
Post Holdings
POST
$4.14B
| $883K | ﹤0.01% |
12,374
-113,221
| -90% | -$7.75M |
|
537
Wynn Resorts
WYNN
$10.3B
| $868K | ﹤0.01% |
6,250
-21
| -0.3% | -$2.56K |
|
|
EGRX
538
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $861K | ﹤0.01% |
14,336
-3,507
| -20% | -$209K |
|
539
Travere Therapeutics
TVTX
$5.2B
| $855K | ﹤0.01% |
60,190
| – | – |
|
|
CLVS
540
DELISTED
Clovis Oncology, Inc.
CLVS
| $845K | ﹤0.01% |
81,089
-39,187
| -33% | -$285K |
|
|
CEO
541
DELISTED
CNOOC Limited
CEO
| $840K | ﹤0.01% |
5,039
-10,295
| -67% | -$1.58M |
|
|
CS
542
DELISTED
Credit Suisse Group
CS
| $839K | ﹤0.01% |
62,404
-6,208
| -9% | -$79.3K |
|
543
Northrop Grumman
NOC
$77.1B
| $826K | ﹤0.01% |
2,401
+1,064
| +80% | +$374K |
|
544
Marathon Petroleum
MPC
$92.4B
| $820K | ﹤0.01% |
13,612
+4,433
| +48% | +$277K |
|
545
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.4B
| $820K | ﹤0.01% |
23,460
-13,910
| -37% | -$462K |
|
|
HOLX
546
DELISTED
Hologic
HOLX
| $819K | ﹤0.01% |
15,693
+111
| +0.7% | +$5.53K |
|
547
Boston Scientific
BSX
$69.5B
| $804K | ﹤0.01% |
17,771
+438
| +3% | +$18.3K |
|
548
B&G Foods
BGS
$287M
| $796K | ﹤0.01% |
44,403
+10
| +0% | +$168 |
|
549
Starbucks
SBUX
$120B
| $776K | ﹤0.01% |
8,828
+1,141
| +15% | +$97.3K |
|
550
Phillips 66
PSX
$84.9B
| $775K | ﹤0.01% |
6,952
+1,495
| +27% | +$168K |
|
Similar funds
Ken Fisher's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Fisher held 981 positions worth $99B, up 8.6% from $91.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Fisher's Q4 2019 filing shows 78 new, 256 increased, 457 reduced and 83 closed positions. Its largest new stake was Enterprise Products Partners: 584,777 shares worth $16.5M. The largest sale was TSMC, an estimated $171M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2019 buy was Enterprise Products Partners: 584,777 shares worth $16.5M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $274M increase.
- Ken Fisher's biggest Q4 2019 reduction was TSMC, cutting an estimated $171M.
- Ken Fisher fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $61.9M.
- Ken Fisher's ten largest holdings make up 28% of its $99B portfolio in Q4 2019.
- Ken Fisher opened 78 new positions and closed 83 in Q4 2019.
- Ken Fisher's portfolio value rose 8.6% quarter-over-quarter to $99B.
Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.